Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX<sup>®</sup> Modified Release Tablets in Healthy Male and Female Volunteers

Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX<sup>®</sup> Modified Release Tablets in Healthy Male and Female Volunteers

The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enrolled healthy men and post-menopausal women received modified release tablets containing 600 mg of the oral non-absorbable...

Full description

Bibliographic Details
Main Authors: Andrea Francesco Daniele Di Stefano, Milko Massimiliano Radicioni, Angelo Vaccani, Alessandro Mazzetti, Luigi Maria Longo, Luigi Moro
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Antibiotics
Subjects:
non absorbable antibiotics
rifamycin SV
pharmacokinetics
healthy subjects
MMX
Online Access:https://www.mdpi.com/2079-6382/10/2/167

Internet

https://www.mdpi.com/2079-6382/10/2/167

Similar Items